Milrinone for Prevention of Post-ligation Cardiac Syndrome Trial
NCT06679855
·
clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
316
Enrollment
NETWORK
Sponsor class
Conditions
Post-ligation Cardiac Syndrome
Interventions
DRUG:
Milrinone infusion
DRUG:
Placebo infusion
Sponsor
NICHD Neonatal Research Network
Collaborators
[object Object]